MDGL Message Board Post 10868312 | Madrigal Pharmaceuticals...
home / stock / mdgl / mdgl message board
(investorshangout)
Posted on: Aug/31/2022 18:25:53
Source: investorshangout
https://investorshangout.com/post/view?id=6463790
whytestocks: $MDGL News Article - Madrigal Pharmaceuticals Initiates the MAESTRO-NASH Outcomes Study Evaluating R
News, Short Squeeze, Breakout and More Instantly...
Madrigal Pharmaceuticals Inc. Company Name:
MDGL Stock Symbol:
Market:
Madrigal Pharmaceuticals Inc. Website:
-
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
-
On March 14, 2024, received U.S. FDA approval of Rezdiffra™ (resmetirom) for the treatment of patients with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis In April 2024, product shipped and first patients received Rezdiffra, the first and ...